Fungal cell wall vaccines: An update

Journal of Medical Microbiology

Volumn 61, Issue PART7, 2012, Pages 895-903

  Edwards, John E ^a  

^a LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; CANDIDA ALBICANS VACCINE; CELL MEMBRANE PROTEIN; DECTIN 1; DNA VACCINE; FUNGUS VACCINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 22; LIVE VACCINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCLONAL ANTIBODY;

BACTERIAL STRAIN; CANDIDA ALBICANS; CELL ACTIVITY; CELL WALL; COCCIDIOIDOMYCOSIS; CRYPTOCOCCOSIS; CYTOKINE PRODUCTION; DRUG EFFICACY; FUNGAL CELL; HISTOPLASMOSIS; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNIZATION; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PNEUMOCYSTIS; PRIORITY JOURNAL; REVIEW; SACCHAROMYCES CEREVISIAE; SOUTH AMERICAN BLASTOMYCOSIS; TH1 CELL; TH17 CELL; VACCINATION; VAGINITIS;

EID: 84862655303     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.041665-0     Document Type: Review

References (60)

1. Awasthi, S. (2007). Dendritic cell-based vaccine against coccidioides infection. Ann N Y Acad Sci 1111, 269-274.
2. Bozza, S., Gaziano, R., Lipford, G. B., Montagnoli, C., Bacci, A., Di Francesco, P., Kurup, V. P., Wagner, H. & Romani, L. (2002). Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. Microbes Infect 4, 1281-1290.
3. Bozza, S., Perruccio, K., Montagnoli, C., Gaziano, R., Bellocchio, S., Burchielli, E., Nkwanyuo, G., Pitzurra, L., Velardi, A. & Romani, L. (2003). A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood 102, 3807-3814.
4. Brandhorst, T. T., Wüthrich, M., Warner, T. & Klein, B. (1999). Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis. J Exp Med 189, 1207-1216.
5. Brito, L. A., Chan, M., Baudner, B., Gallorini, S., Santos, G., O'Hagan, D. T. & Singh, M. (2011). An alternative renewable source of squalene for use in emulsion adjuvants. Vaccine 29, 6262-6268.
6. Capilla, J., Clemons, K. V., Liu, M., Levine, H. B. & Stevens, D. A. (2009). Saccharomyces cerevisiae as a vaccine against coccidioidomycosis. Vaccine 27, 3662-3668.
7. Cassone, A. (2008). Fungal vaccines: real progress from real challenges. Lancet Infect Dis 8, 114-124.
8. Chow, S. K. & Casadevall, A. (2011). Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis. Vaccine 29, 1891-1898.
9. Correia, A., Lermann, U., Teixeira, L., Cerca, F., Botelho, S., da Costa, R. M. G., Sampaio, P., Gärtner, F., Morschhäuser, J. & other authors (2010). Limited role of secreted aspartyl proteinases Sap1 to Sap6 in Candida albicans virulence and host immune response in murine hematogenously disseminated candidiasis. Infect Immun 78, 4839- 4849.
10. Cutler, J. E., Deepe, G. S., Jr & Klein, B. S. (2007). Advances in combating fungal diseases: vaccines on the threshold. Nat Rev Microbiol 5, 13-28.
11. Deepe, G. S., Jr (1997). Prospects for the development of fungal vaccines. Clin Microbiol Rev 10, 585-596.
12. Deepe, G. S., Jr, Wüthrich, M. & Klein, B. S. (2005). Progress in vaccination for histoplasmosis and blastomycosis: coping with cellular immunity. Med Mycol 43, 381-389.
13. Feldmesser, M. (2005). Prospects of vaccines for invasive aspergillosis. Med Mycol 43, 571-587.
14. Feng, Y., Guo, S., Jiang, T., Han, X., Liu, P., Wu, T. & Luo, Y. (2011). Active immunization against Pneumocystis carinii with p55-v3 DNA vaccine in rats. Can J Microbiol 57, 375-381.
15. Fernandes, V. C., Martins, E. M., Boeloni, J. N., Coitinho, J. B., Serakides, R. & Goes, A. M. (2011). Additive effect of rPb27 immunization and chemotherapy in experimental paracoccidioidomycosis. PLoS ONE 6, e17885.
16. Fidel, P. L., Jr & Cutler, J. E. (2011). Prospects for development of a vaccine to prevent and control vaginal candidiasis. Curr Infect Dis Rep 13, 102-107.
17. Galgiani, J. N., Peng, T., Lewis, M. L., Cloud, G. A., Pappagianis, D. & The National Institute of Allergy and Infectious Diseases Mycoses Study Group (1996). Cerebrospinal fluid antibodies detected by ELISA against a 33-kDa antigen from spherules of Coccidioides immitis in patients with coccidioidal meningitis. J Infect Dis 173, 499- 502.
18. Garcia, J. P. & Howard, D. H. (1971). Characterization of antigens from the yeast phase of Histoplasma capsulatum. Infect Immun 4, 116-125.
19. Gomez, F. J., Gomez, A. M. & Deepe, G. S., Jr (1991). Protective efficacy of a 62-kilodalton antigen, HIS-62, from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect Immun 59, 4459-4464.
20. Gomez, F. J., Allendoerfer, R. & Deepe, G. S., Jr (1995). Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis. Infect Immun 63, 2587-2595.
21. Hennessey, J. P., Jr, Schmidt, C. S., Ibrahim, A., Filler, S., White, C. J., Yeaman, M., Fu, Y. & Edwards, J. E. (2011). A Phase 1 clinical evaluation of NDV3, a vaccine to prevent disease caused by Candida spp. and Staphylococcus aureus. In 51st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago. Washington, DC: American Society for Microbiology.
22. Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J. W., Kern, W. V., Marr, K. A., Ribaud, P. & other authors (2002). Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347, 408-415.
23. Hoyer, L. L., Scherer, S., Shatzman, A. R. & Livi, G. P. (1995). Candida albicans ALS1: domains related to a Saccharomyces cerevisiae sexual agglutinin separated by a repeating motif. Mol Microbiol 15, 39-54.
24. + T cells to protect against histoplasmosis. Infect Immun 79, 4493-4502.
25. Hung, C. Y., Gonzalez, A., Wüthrich, M., Klein, B. S. & Cole, G. T. (2011). Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17). Infect Immun 79, 4511-4522.
26. Ibrahim, A. S., Spellberg, B. J., Avenissian, V., Fu, Y., Filler, S. G. & Edwards, J. E., Jr (2005). Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity. Infect Immun 73, 999-1005.
27. Ito, J. I., Lyons, J. M., Diaz-Arevalo, D., Hong, T. B. & Kalkum, M. (2009). Vaccine progress. Med Mycol 47 (Suppl. 1), S394-S400.
28. Johnson, S. M., Kerekes, K. M., Lunetta, J. M. & Pappagianis, D. (2007a). Characteristics of the protective subcellular coccidioidal T27K vaccine. Ann N Y Acad Sci 1111, 275-289.
29. Johnson, S. M., Lerche, N. W., Pappagianis, D., Yee, J. L., Galgiani, J. N. & Hector, R. F. (2007b). Safety, antigenicity, and efficacy of a recombinant coccidioidomycosis vaccine in cynomolgus macaques (Macaca fascicularis). Ann N Y Acad Sci 1111, 290-300.
30. Kirkland, T. N. & Fierer, J. (1985). Genetic control of resistance to Coccidioides immitis: a single gene that is expressed in spleen cells determines resistance. J Immunol 135, 548-552.
31. Kirkland, T. N., Raz, E. & Datta, S. K. (2006). Molecular and cellular mechanisms of protective immunity to coccidioidomycosis. Vaccine 24, 495-500.
32. Klein, B. S. & Jones, J. M. (1994). Purification and characterization of the major antigen WI-1 from Blastomyces dermatitidis yeasts and immunological comparison with A antigen. Infect Immun 62, 3890- 3900.
33. Lin, L., Ibrahim, A. S., Xu, X., Farber, J. M., Avanesian, V., Baquir, B., Fu, Y., French, S. W., Edwards, J. E., Jr & Spellberg, B. (2009). Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog 5, e1000703.
34. Liu, M., Clemons, K. V., Bigos, M., Medovarska, I., Brummer, E. & Stevens, D. A. (2011a). Immune responses induced by heat killed Saccharomyces cerevisiae: a vaccine against fungal infection. Vaccine 29, 1745-1753.
35. Liu, M., Capilla, J., Johansen, M. E., Alvarado, D., Martinez, M., Chen, V., Clemons, K. V. & Stevens, D. A. (2011b). Saccharomyces as a vaccine against systemic aspergillosis: 'the friend of man' a friend again? J Med Microbiol 60, 1423-1432.
36. Lunetta, J. M., Simmons, K. A., Johnson, S. M. & Pappagianis, D. (2007). Molecular cloning and expression of a cDNA encoding a Coccidioides posadasii 1,2-alpha-mannosidase identified in the coccidioidal T27K vaccine by immunoproteomic methods. Ann N Y Acad Sci 1111, 164-180.
37. Pappagianis, D. & Levine, H. B. (1975). The present status of vaccination against coccidioidomycosis in man. Am J Epidemiol 102, 30-41.
38. Pappagianis, D. & The Valley Fever Vaccine Study Group (1993). Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. Am Rev Respir Dis 148, 656-660.
39. Pappas, P. G., Rex, J. H., Lee, J., Hamill, R. J., Larsen, R. A., Powderly, W., Kauffman, C. A., Hyslop, N., Mangino, J. E. & other authors (2003). A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 37, 634-643.
40. Perruccio, K., Bozza, S., Montagnoli, C., Bellocchio, S., Aversa, F., Martelli, M., Bistoni, F., Velardi, A. & Romani, L. (2004). Prospects for dendritic cell vaccination against fungal infections in hematopoietic transplantation. Blood Cells Mol Dis 33, 248-255.
41. Phan, Q. T., Myers, C. L., Fu, Y., Sheppard, D. C., Yeaman, M. R., Welch, W. H., Ibrahim, A. S., Edwards, J. E., Jr & Filler, S. G. (2007). Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol 5, e64.
42. Pietrella, D., Rachini, A., Torosantucci, A., Chiani, P., Brown, A. J., Bistoni, F., Costantino, P., Mosci, P., d'Enfert, C. & other authors (2010). A b-glucan-conjugate vaccine and anti-b-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique. Vaccine 28, 1717-1725.
43. Saville, S. P., Lazzell, A. L., Chaturvedi, A. K., Monteagudo, C. & Lopez-Ribot, J. L. (2008). Use of a genetically engineered strain to evaluate the pathogenic potential of yeast cell and filamentous forms during Candida albicans systemic infection in immunodeficient mice. Infect Immun 76, 97-102.
44. + T cells. J Immunol 169, 5818-5826.
45. Shao, C., Qu, J., He, L., Zhang, Y., Wang, J., Zhou, H., Wang, Y. & Liu, X. (2005). Dendritic cells transduced with an adenovirus vector encoding interleukin-12 are a potent vaccine for invasive pulmonary aspergillosis. Genes Immun 6, 103-114.
46. Sheppard, D. C., Yeaman, M. R., Welch, W. H., Phan, Q. T., Fu, Y., Ibrahim, A. S., Filler, S. G., Zhang, M., Waring, A. J. & Edwards, J. E., Jr (2004). Functional and structural diversity in the Als protein family of Candida albicans. J Biol Chem 279, 30480-30489.
47. Shubitz, L. F., Dial, S. M., Perrill, R., Casement, R. & Galgiani, J. N. (2008). Vaccine-induced cellular immune responses differ from innate responses in susceptible and resistant strains of mice infected with Coccidioides posadasii. Infect Immun 76, 5553-5564.
48. Spellberg, B. (2011). Vaccines for invasive fungal infections. F1000 Med Rep 3, 13.
49. Spellberg, B., Ibrahim, A. S., Yeaman, M. R., Lin, L., Fu, Y., Avanesian, V., Bayer, A. S., Filler, S. G., Lipke, P. & other authors (2008). The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus. Infect Immun 76, 4574-4580.
50. Stevens, D. A., Clemons, K. V. & Liu, M. (2011). Developing a vaccine against aspergillosis. Med Mycol 49 (Suppl. 1), S170-S176.
51. Tarcha, E. J., Basrur, V., Hung, C. Y., Gardner, M. J. & Cole, G. T. (2006). Multivalent recombinant protein vaccine against coccidioidomycosis. Infect Immun 74, 5802-5813.
52. Tewari, R. P., Sharma, D. K. & Mathur, A. (1978). Significance of thymus-derived lymphocytes in immunity elicited by immunization with ribosomes or live yeast cells of Histoplasma capsulatum. J Infect Dis 138, 605-613.
53. Torosantucci, A., Bromuro, C., Chiani, P., De Bernardis, F., Berti, F., Galli, C., Norelli, F., Bellucci, C., Polonelli, L. & other authors (2005). A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med 202, 597-606.
54. Wüthrich, M., Krajaejun, T., Shearn-Bochsler, V., Bass, C., Filutowicz, H. I., Legendre, A. M. & Klein, B. S. (2011a). Safety, tolerability, and immunogenicity of a recombinant, genetically engineered, live-attenuated vaccine against canine blastomycosis. Clin Vaccine Immunol 18, 783-789.
55. Wüthrich, M., Gern, B., Hung, C. Y., Ersland, K., Rocco, N., Pick-Jacobs, J., Galles, K., Filutowicz, H., Warner, T. &other authors (2011b). Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J Clin Invest 121, 554-568.
56. Wyckoff, E. E., Pishko, E. J., Kirkland, T. N. & Cole, G. T. (1995). Cloning and expression of a gene encoding a T-cell reactive protein from Coccidioides immitis: homology to 4-hydroxyphenylpyruvate dioxygenase and the mammalian F antigen. Gene 161, 107-111.
57. Xin, H. & Cutler, J. E. (2011). Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis. Clin Vaccine Immunol 18, 1656-1667.
58. Xin, H., Dziadek, S., Bundle, D. R. & Cutler, J. E. (2008). Synthetic glycopeptide vaccines combining b-mannan and peptide epitopes induce protection against candidiasis. Proc Natl Acad Sci U S A 105, 13526-13531.
59. Xue, J., Chen, X., Selby, D., Hung, C. Y., Yu, J. J. & Cole, G. T. (2009). A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis. Infect Immun 77, 3196-3208.
60. Zelante, T., De Luca, A., Bonifazi, P., Montagnoli, C., Bozza, S., Moretti, S., Belladonna, M. L., Vacca, C., Conte, C. & other authors (2007). IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 37, 2695-2706.